# MONJUVI
> **BLA761163** · Biologics License Application · Sponsor: MORPHOSYS US INC · Approved 2020-07-31
## Drug
- **FDA Application Number:** BLA761163
- **Application type:** Biologics License Application
- **Brand name:** MONJUVI
- **Generic name:** TAFASITAMAB-CXIX
- **Active ingredients:** TAFASITAMAB-CXIX
- **Dosage form:** SOLUTION
- **Route:** INTRAVENOUS
- **Marketing status:** Prescription
- **Sponsor:** MORPHOSYS US INC
- **Manufacturer:** Incyte Corporation
- **First approval:** 2020-07-31
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761163)
---
*AI Analytics · CC0 1.0*